Atlas Trials

A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

Clinical trial NCT06581627 · COMPLETED

Trial details

NCT number
NCT06581627
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteersSickle Cell DiseaseThalassemia
Start date
2024-08-26
Primary completion
2024-10-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.